First Pertuzumab Biosimilar Earns FDA Nod for Breast Cancer – Medscape

1. First Pertuzumab Biosimilar Earns FDA Nod for Breast Cancer  Medscape
2. Roche’s Perjeta faces first biosimilar threat in US with clearance of interchangeable from Henlius  FirstWord Pharma
3. Shanghai Henlius Biotech’s HLX11 Receives FDA Approval for Breast Cancer Treatment  TipRanks
4. Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar  MedPage Today
5. FDA Approves Pertuzumab Biosimilar in Breast Cancer Indications  CancerNetwork

Continue Reading